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A B S T R A C T
Monitoring systems (MS) provide additional information that many developers and researchers expect will re-
duce the uncertainty surrounding decision-making in livestock production and therefore enhance management
decisions. However, the actual economic value of the information (VoI) yielded by MS has hardly been in-
vestigated. The aim of this study was to ﬁll that void based on two objectives. The ﬁrst is to estimate the VoI of
MS prior to implementation using decision analysis based on scarce data from diﬀerent sources. The second
objective is to identify which factors most inﬂuence the VoI of MS and to develop recommendations about the
focus of future MS development. To illustrate our objectives, we used a case study of two milk biomarkers used to
monitor subacute ruminal acidosis (SARA) in dairy cows: fat-to-protein ratio (FPR) and the fatty acid proﬁle
(FAP). FPR is presently used to monitor SARA, while FAP is a newly developed test, currently in the pre-com-
mercial phase, with reports of better accuracy than FPR. A stochastic decision tree model was used to estimate
the expected monetary value of three levels of information with regards to SARA: (i) no monitoring, monitoring
(ii) with FPR or (iii) with FAP. The VoI of FPR and FAP were calculated as the diﬀerence in expected monetary
value of monitoring with FPR and FAP as compared with no monitoring, respectively. Several scenarios were
modeled using sensitivity and elasticity analyses. The aim was not only to compensate for the scarcity of data for
some variables, but also to identify under which conditions decisions based on FAP monitoring were indeed the
best. In all the scenarios, monitoring SARA with FPR had the lowest expected monetary value. No monitoring
was a better decision in 70% of the iterations in the scenario that described the most probable situation. The VoI
of FAP was positive when SARA prevalence was between 0.21 and 0.79 with its maximum value at 0.61, when
the treatment costs were lower than €116/case/year and when the disease costs were higher than €260/case/
year. Moreover, an increase of speciﬁcity of the FAP to 0.95 yielded a positive VoI, whereas an increase of its
sensitivity to 1.0 still yielded a negative VoI, suggesting that developers of the FAP should focus on improving its
speciﬁcity rather than its sensitivity. To avoid suboptimal use of ﬁnite resources while developing MS, we
recommend ex-ante investigation of the VoI of the MS under development.
1. Introduction
Monitoring systems (MS) measure health and production provide
additional information. But to what extent does this information actu-
ally improve health management? Evaluating the value of information
(VoI) derived from the use of MS is central to answering this question.
The VoI is deﬁned “as the expected utility with information minus the
expected utility without information” (Kristensen, 2015, p. 229) that
can be expressed in economic terms. Generally, a farmer will choose to
invest in a MS if its associated beneﬁts exceed its costs, thus deriving a
high VoI and (higher) proﬁtability (Russel and Bewley, 2013;
Steeneveld et al., 2015). In a study of Kentucky (USA) dairy farmers,
lack of knowledge on the economic value of MS represents a barrier to
implementation (Russel and Bewley, 2013). Although numerous MS can
monitor and detect diﬀerent health and production issues (Zank and
Schlatterer, 1998; Jorjong et al., 2014), only a few studies have
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investigated their proﬁtability and value (Rutten et al., 2013; van der
Voort et al., 2017). The paucity of studies may have several causes.
First, according to Verstegen et al. (1995), the intangible nature of the
beneﬁts derived from the use of MS hampers their evaluation with
traditional economic approaches such as cost-beneﬁt analysis. More-
over, when beneﬁts are tangible, one bottleneck may be the limited
availability of economic methodologies that can investigate the VoI of
MS (Verstegen et al., 1995) without bias. The research designs to esti-
mate the VoI of MS are classiﬁed into positive and normative ap-
proaches (Verstegen et al., 1995) which are conducted ex-post and ex-
ante, respectively. Selection bias is typically encountered in positive
approaches. This is introduced when randomization of participants
(e.g., farmers) cannot be ensured. For instance, participants may be
better farm managers and, in turn, have better farm performance
parameters than non-participants. Furthermore, problems of attribution
might also arise if the size eﬀect of the group using the MS is not
compared to a control group. Accordingly, this approach disregards the
fact that the observed diﬀerences in the group using the MS may be
caused by other changes that were not controlled for by randomization.
Both selection bias and the attribution problem are diﬃcult to prevent
without conducting experimental studies (Verstegen et al., 1995) that
are typically expensive and sometimes impossible to perform. On the
other hand, normative approaches rely heavily on prior knowledge of
the economic impact caused by the health problem and by the possible
interventions. The disease costs of ketosis (Raboisson et al., 2015;
McArt et al., 2015; Liang et al., 2015; Mostert et al., 2017), other me-
tabolic diseases (Kaneene and Hurd, 1990; van der Voort and
Hogeveen, 2016) and costs of treatment of metabolic diseases
(Fourichon et al., 2001) have been studied, but for other diseases both
disease and treatment costs remain unknown (van der Voort et al.,
2017). As a consequence, limited data availability becomes one of the
main challenges when conducting a normative economic analysis of the
VoI provided by MS (Steeneveld et al., 2015; van der Voort et al., 2017;
Van De Gucht et al., 2018). In order to compensate for data scarcity,
several alternatives can be used such as elasticity and sensitivity ana-
lyses (Bewley et al., 2010; Down et al., 2017), together with combining
data from diﬀerent available sources such as published literature and
reports, expert opinion, and ﬁtted distributions. For issues that are
important and unexplored (such as the presented issue of the VoI of MS)
Hardaker and Lien (2010) advocate the use of data from diﬀerent re-
sources instead of deviating the attention towards problems for which
frequentist datasets are available.
Another reason for a small number of studies on the VoI of MS may
be that the examined VoI of MS has been reported as being rather low
and largely dependent on the accuracy of the MS in the reference si-
tuation (Jørgensen, 1993; van Asseldonk et al., 1999; Bewley et al.,
2010; Jago et al., 2011; Kristensen et al., 2012; Giordano, 2014; Cha
et al., 2016). As a result, researchers and developers may have had a
hard time reconciling the low estimated VoI of MS as compared to their
expectations (Bewley et al., 2010), and, as a consequence, they might
have little interest in either estimating or reporting the VoI (Cornou and
Kristensen, 2013). Nevertheless, many MS may still be of value to the
decision-maker. Ex-ante studies can shed light on this value and its
inﬂuencing factors. Hence, ex-ante assessment of the potential value of
MS can help steer research and development towards aspects that can
increase the value of MS.
Before embarking on further optimization of MS, developers must
choose whether to focus on (i) improving its accuracy (e.g., whether it
is more important to improve the sensitivity or speciﬁcity of the MS),
(ii) identifying (or selecting) speciﬁc groups of animals at higher risk
(i.e., higher prevalence), or (iii) improving knowledge about the costs
of the condition being monitored (e.g., disease and treatment costs).
This aspect has often been neglected in previous literature, with the
exception of the studies by Bewley et al. (2010) and Van De Gucht et al.
(2018). In the former study, the proﬁtability of using an automatic body
score system was assessed to guide researchers about goal-setting in
light of ﬁnite research and development funds. A recent study had a
similar goal and explored factors driving the economic value of auto-
matic lameness detection systems in dairy cattle (Van De Gucht et al.,
2018). Furthermore, ex-ante studies into the VoI can inform developers
about the type and nature of the health and production problems for
which a certain MS provides the most value.
The primary objective of this study is to present a method to
quantify the VoI of MS using a decision analytical approach (Verstegen
et al., 1995). To illustrate this objective we used a numerical example
based on two diagnostic tests that detect subacute ruminal acidosis
(SARA): (i) the fat-to-protein ratio (FPR) and (ii) the fatty acid proﬁle
(FAP). The former is currently used to detect SARA in Belgium (De
Brabander et al., 2011) and the latter is in a pre-commercial phase; it
has shown a similar sensitivity (Se) but a better speciﬁcity (Sp) than the
FPR. The secondary objective is to provide insight into the factors in-
ﬂuencing the VoI of the FAP, resulting in recommendations for the
developers’ focus when optimizing the MS in order to best allocate
limited (capital, labor) resources.
2. Materials and methods
2.1. Procedure
Our procedure consisted of a stochastic decision tree simulation
model applied to a typical Belgian specialized dairy farm. The sto-
chastic decision tree simulates the impact of managing SARA, by means
of the expected monetary value (EMV), using three potential decisions
regarding its monitoring: (i) no monitoring at all, a strategy allowing
herd-level decisions only; (ii) cow-level monitoring based on FPR; and
(iii) cow-level monitoring based on FAP-based models. The latter two
approaches imply that SARA treatment decisions are made at cow level,
with the aim of maximizing herd-level economic performance. To es-
timate the VoI of MS we used the model framework suggested by
Cornou and Kristensen (2013), where the VoI is estimated as the value
of the decision based on the piece of information as compared to the
value of the decision without having the information. The VoI of FAP
and FPR were estimated as the diﬀerence between the EMV of the
strategy to manage SARA based on monitoring results from FAP and
FPR, respectively, minus the EMV of the strategy used to manage SARA
without monitoring.
This stochastic decision tree simulation model was fed with data of
the test characteristics of FAP and FPR, true prevalence (True Prev),
disease costs (DC), and treatment costs (TC). Data on the costs of ob-
taining the additional information by using the biomarkers were not
accounted for into our model and a value of €0 was inserted. This would
provide insight into whether the biomarkers provided a value regard-
less of the cost of obtaining the extra information. In the situations in
which the biomarkers had a value, this would represent the sensible
upper limit that an economically rational farmer should pay to obtain
the additional information. The data on the True Prev, DC and TC were
scarce; we used the methodology proposed by Hardaker and Lien
(2010) to address the evaluation of diﬀerent potential decisions in si-
tuations of limited available data. In this case, Hardaker and Lien
(2010) advocate the use of a combination of ﬁtted distributions, data
obtained from previous literature, and reports combined with expert
judgement modeled as subjective probabilities. Data gathered from
literature, consultation with experts, dairy cattle veterinarians, and feed
advisors resulted in information on the True Prev of SARA, TC of SARA,
and DC of SARA. In addition, several scenarios were simulated in sen-
sitivity and elasticity analyses. We chose these analyses in accordance
to other studies investigating the economic impact of MS (Bewley et al.,
2010; Giordano, 2014) as this was reported as a way to account for the
uncertainty of these data and to identify the combinations of variables
that render FAP valuable.
The data used for the test characteristics of FAP and FPR originated
from four previously conducted experiments, that aimed at identifying
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relevant milk fatty acids to diagnose SARA and reported the Se and Sp
of the FPR (Colman et al., 2015) and the FAP (Colman, 2012). The
ability of a diagnostic test to correctly diagnose positive and negative
cases is deﬁned by its Se and Sp, respectively.
The diﬀerent components of the stochastic decision tree simulation
model and data which served as input into our procedure are presented
in detail below.
2.2. Test characteristics of FAP and FPR
To estimate the test characteristics of the milk biomarkers we used
four datasets of four acidosis induction experiments in rumen-ﬁstulated
dairy cows (Colman et al., 2015). A brief description of the four datasets
(1.1, 1.2, 2 and 4) can be found in Appendix A. To estimate the test
characteristics of the FPR and the FAP, the ruminal pH was con-
tinuously measured. The datasets 1.1, 1.2, 2, and 4 were used to esti-
mate the Se and Sp of the FPR (Colman et al., 2015). Datasets 1.1 and
1.2 were used to estimate the test characteristics of the FAP (Colman,
2012).
FPR was measured using Fourier Transformed-infrared spectro-
scopy. Eq. (1) presents a formula that estimates the normal FPR range
for a cow in a speciﬁc season and in a speciﬁc lactation period (De
Brabander et al., 2011).
= +
+ ±
Normal FPR range average FPR Season Correction Factor
DIM Correction Factor 0.04 (1)
Before the normal FPR range can be estimated, the average FPR for
the last 12 months of one cow is required. Subsequently, the average
FPR has to be corrected for the season and the lactation period. The
season correction factor is +0.03 during the conﬁned (inside the barn)
period and −0.03 during the grazing period. The days in milk (DIM)
correction factor is +0.05 if the cow has less than 100 DIM and−0.01
if the cow has more than 100 DIM. A correction factor of 0.04 is sub-
tracted or added to take the individual variations between cows into
account.
The estimated normal FPR range is subsequently compared to the
measured FPR: if the measured FPR is lower than the lower limit of the
normal FPR range, then the cow is diagnosed with SARA. Across the
four datasets (datasets 1.1, 1.2, 2, and 4), FPR presented a Se of 0.72
and a Sp of 0.314 (Table 1).
In datasets 1.1 and 1.2 the milk FAP was identiﬁed and quantiﬁed
by gas chromatography on a CP-Sil88 column for milk fatty acids
(methyl esters) after extraction of the milk fat (Chouinard et al., 1997)
and methylation (Stefanov et al., 2010). Colman et al. (2015) developed
SARA classiﬁcation models using support vector machine approaches
which served as discrimination analysis to estimate the Se and Sp of the
FAP in the two datasets. Depending on the dataset used, the FAP had a
Se between 0.56 and 0.80 and its Sp was between 0.70 and 0.90
(Colman et al., 2015). Further, the receiving operating characteristics
(ROC) curve with data of datasets 1.1 and 1.2 was used to determine
the combination of plausible test characteristics of FAP (Fig. 1)
(Colman, 2012). The ten diﬀerent combinations of SeFAP and SpFAP used
in further analyses are indicated in Fig. 1. The combination of Se and Sp
indicated by number 2, which had a Se of 0.64 and a Sp of 0.89, was
used in the default scenario and the elasticity analyses (the details of
these scenarios are provided in Section 2.7).
2.3. Disease costs of SARA
The DC incurred by cows with SARA is caused by decreased milk
production, decreased eﬃciency of milk production, premature culling,
and increased death rates (Krause and Oetzel, 2006). Similarly, Plaizier
et al. (2009) report consequences such as lower feed intake, reduced
ﬁber digestion, lower milk fat, diarrhea, laminitis, liver abscesses, in-
creased production of bacterial endotoxins and inﬂammation char-
acterized by increases in acute phase proteins. Although SARA occurs
very frequently and has a high incidence in some herds, reports on the
costs associated with SARA are scarce. Donovan (1997) stated that the
costs of SARA in the dairy cow industry in the USA could be estimated
between USD 500 million to USD 1 billion per year and the costs per
aﬀected cow (hereafter referred to as ‘cases’) was estimated as USD 1.12
per case/day or USD 409 per case/year. Stone (1999) demonstrated
that SARA reduced milk production by 2.7 kg/day, milk fat production
by 0.3% and milk protein production by 0.12%, resulting in direct costs
of USD 400/case/year to USD 450/case/year. Similarly, Bipin et al.
(2016) found a milk yield reduction of 2.8 l/day and a milk fat de-
pression of 0.4% in dairy commercial herds in India. Formigoni (1998)
estimated the cost of SARA in Italy to be approximately €260/case/
year. According to an estimation performed by a dairy farm advisor in
the Netherlands in a non-peer-reviewed publication (van Laarhoven,
2012) the presumable costs of SARA, including the indirect costs, to-
taled to €210/case/year which accounted for the increased indirect
costs due to extra laminitis treatments (€10.50 to €24.50/case/year),
milk losses due to lameness (8–15%), increased culling rate due to lame
cows (4–20%), and costs for a longer calving interval (€0.70 to €1.67/
case/year). van Laarhoven (2012) developed a farm-economic model to
estimate the consequences of implementing measures to prevent SARA.
The input data on the productivity was obtained from Dutch dairy
farms that achieved a reduction in the prevalence of SARA from 23% to
5%. Because the estimation by van Laarhoven (2012) was the newest
Table 1
Test characteristics of the fat-to-protein ratio (FPR) to diagnose subacute ruminal acidosis
in the four datasets (1.1, 1.2, 2 and 4) from Colman et al. (2015).
Dataset 1.1 1.2 2 4 Weighted average
Number of observations 48 78 132 107
Se FPRa 0.2000 1.00 0.8240 0.6210 0.7200
Sp FPRb 0.7080 0.1540 0.3780 0.1760 0.3143
a Sensitivity.
b Speciﬁcity.
Fig. 1. Receiving operating characteristics curve of the fatty acid proﬁle-based models to
detect subacute ruminal acidosis of a combined dataset of datasets 1.1 and 1.2 (adapted
from Colman, 2012). Point number 21 above the curve served as input data in the default
scenario and elasticity analyses. All the 10 points2 were used in the sensitivity analysis to
explore whether the combination of sensitivity (Se) and speciﬁcity (Sp) of the fatty acid
proﬁle-based models yielded a positive economic value of information. 1 The number 2
displays the combination of sensitivity (Se) (0.64) and speciﬁcity (Sp) (0.89) used in the
default scenario and the elasticity analyses. 2 The 10 numbers on the curve represent the
10 diﬀerent combinations of Se and Sp for which the value of information of the fatty acid
proﬁle versus no monitoring was investigated in the sensitivity analysis. These combi-
nations of Se and Sp are the following: 1: Se= 0.11, Sp=1.00; 2: Se= 0.64, Sp= 0.89;
3: Se= 0.65, Sp= 0.82; 4: Se= 0.77, Sp= 0.77; 5: Se= 0.81, Sp= 0.71; 6: Se= 0.90,
Sp= 0.65; 7: Se= 0.93, Sp= 0.59; 8: Se= 0.93, Sp= 0.54; 9: Se=0.97, Sp= 0.48; 10:
Se= 1.00, Sp= 0.37.
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estimation, and the Dutch and Belgian dairy situations are similar, we
assumed that the most probable value of DC of SARA in Belgium is
€210/case/year. To account for the uncertainty of the limited data
available in literature, we used a Pert distribution for the DC of SARA
using @Risk (@Risk version 7.0, Palisade, Ithaca, NY, USA). The
minimum value was set at €100/case/year, most probable value was
inserted as €210/case/year and maximum was €450/case/year. Fur-
thermore, we estimated the eﬀect of the DC on the VoI of the FAP in the
elasticity analysis-2 (characteristics of the parametrized model are de-
scribed in Section 2.7).
2.4. Treatment costs of SARA
A range of dietary measures are taken to prevent or treat SARA:
most common are a change of diet with or without supplementation
with a buﬀer, reducing the amount of concentrate, and avoiding the
supply of highly fermentable carbohydrates in the concentrate to in-
crease the eﬀective ﬁber in the ration. The use of buﬀers to prevent the
appearance of SARA is used in highly productive herds in the USA
(Hutjens, 1991; Enemark, 2009), and in Europe (De Letter, 2015;
Moerman, 2015). However, the supplementation of buﬀers alone is not
considered a long-term solution when not accompanied with optimi-
zation of the feeding management. These additional management
measures may induce additional costs such as extra labor and/or re-
duced milk production (Enemark, 2009). To our knowledge, there are
no reports of these indirect costs in literature. We therefore assumed
that the TC were due to the supplementation of buﬀers and a change in
the diet consisting of less concentrate and more forage. We also as-
sumed that the treatment will be eﬀective in 100% of the cases and that
consequently, cows which received the buﬀer will be healthy after the
treatment. This represents a best case scenario as complete recovery is
not the case for all treatments (Zamarreño et al., 2003; Colman et al.,
2010, 2012). For instance, the buﬀer treatment in combination with
yeast and vitamin E did not have an eﬀect on SARA occurrence in an
experiment conducted by Colman et al. (2010) and only two out of
three cows were cured when a buﬀer to treat SARA was used pre-
ventively (Colman et al., 2012). The results of our model therefore
represent the upper limit of a best-case scenario.
Several commercial buﬀers are available on the market: sodium or
potassium bicarbonate, sodium sesquicarbonate, sodium bentonite,
calcium carbonate, carbonate of potassium. The ﬁrst is the most com-
monly used in practice, with doses varying between 110 and 225 g/
cow/day, and reported to positively aﬀect milk production, fat per-
centage and dry matter intake (DMI) (Hutjens, 1991). A Belgian com-
pound feed company producing and commercializing an additive with
sodium bicarbonate advises administration of 250 g/cow/day (Kampf
and Segers, 2015) as a standard ingredient in the ration which costs
between €0.40/kg and €0.45/kg. These costs total to an average annual
cost of €37 to €41/case/year. We assumed that the costs of reducing the
amount of concentrate in the diet and increasing the forage as well as
the additional labor involved will incur costs between €70 and €250/
case/year. As no data were available and no one cost seemed more
probable than another, we deﬁned the TC as a uniform distribution
with @risk in which the costs could range between €20 - €250/case/
year. Similar to DC, the eﬀect of TC on the VoI of FAP versus no
monitoring was investigated in the elasticity analysis-3 (further de-
tailed in Section 2.7).
2.5. True prevalence of SARA
Data on True Prev of SARA in commercial dairy herds were obtained
from six previous studies (O’Grady et al., 2008; Kleen et al., 2009, 2013;
Tajik et al., 2009; Kitkas et al., 2013; Stefańska et al., 2016). Table 2
details the number of herds used per study and their average prevalence
and supplementary material-1 includes the prevalence per herd. These
studies covered a considerable diversity of diets, ranging from Total
Mixed Ration to grass silage, maize silage supplemented with con-
centrate, and grazing. In four studies the True Prev of SARA in a herd
was estimated as the number of cows which had a ruminal pH lower or
equal to 5.5 (measured in rumen ﬂuid sampled between 3 and 6 h after
feeding). The studies by Stefańska et al. (2016) and by Kleen et al.
(2013) used a pH lower or equal to 5.6. The data on the True Prev of
SARA served as a basis to ﬁt a function with @Risk 7.5 distribution
ﬁtting feature (Palisade Corporation, Ithaca, NY, USA). We selected the
function with the best ﬁt based on their Akaike's Information Criteria
(AIC) (i.e. the ﬁt with a lowest AIC was chosen). The exponential
function (Fig. 2) had the best ﬁt (AIC=−134.86). Furthermore, to
avoid the generation of unrealistic values of True Prev, such as negative
values or values exceeding 1, the ﬁtted distribution was truncated be-
tween 0 and 1. The average of the ﬁtted True Prev was 0.1595 and the
SD was 0.1567. The ﬁtted function was fed into the decision tree as an
input parameter.
2.6. Stochastic decision tree
Fig. 3 displays the decision tree used to perform the decision ana-
lysis in which the three possible decisions that the farmer can take
regarding the monitoring of SARA are depicted: (i) no monitoring, (ii)
monitoring based on FPR, (iii) monitoring based on FAP. The ﬁrst fork,
displaying the choice of no monitoring of SARA, consists of two sec-
ondary forks that depict the choice of treating and not treating the
whole dairy herd. Each of the two secondary forks are followed by a
chance node reﬂecting the proportion of healthy cows and those suf-
fering from SARA. The latter proportion is deﬁned by the True Prev of
SARA and the former by 1 - True Prev. The number of cows with SARA
and the number of healthy cows are calculated based on the total
number of animals in the herd (N) and the True Prev of SARA (Eqs. (2)
and (3), respectively).
= ×# Cows with SARA N True Prev (2)
Table 2
Number of herds included and its average prevalence in each study used to ﬁt the true
prevalence of SARA.
Study Number of herds Mean Preva (SDb)
O’Grady et al. (2008) 12 0.1108 (0.0988)
Kleen et al. (2009) 18 0.1153 (0.1175)
Tajik et al. (2009) 10 0.2433 (0.1799)
Kitkas et al. (2013) 12 0.1581 (0.1579)
Kleen et al. (2013) 26 0.1992 (0.1641)
Stefańska et al. (2016) 9 0.1467 (0.1303)
Total 87 0.1636 (0.1522)
a Prevalence.
b Standard deviation.
Fig. 2. Exponentially ﬁtted function (black line) of the true prevalence of subacute
ruminal acidosis of 87 herds as reported in literature1 (grey bars). 1O’Grady et al. (2008),
Kleen et al. (2009), Tajik et al. (2009), Kitkas et al. (2013), Kleen et al. (2013), Stefańska
et al. (2016).
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= × −# Healthy cows N (1 True Prev) (3)
We assume that the farmer's decision to treat or not the herd – what
we referred to as the ‘no monitoring’ decision – would depend on which
decision entails the maximum EMV as described by Eq. (4).
=EMV Max of{EMV ; EMV }no monitoring all none (4)
With EMVall and EMVnone calculated as Eqs. (5) and (6), respec-
tively, where NCFI is the net cash farm income and it is an indicator of
the economic situation of the farm.1
= ×EMV N (NCFI – TC)all (5)
= × − ×EMV N (NCFI True Prev DC)none (6)
The second and third decision forks outline the decision to use a
milk biomarker to diagnose SARA. Both forks are followed by two
chance branches reﬂecting the probability that a number of cows in the
herd will either have SARA or be healthy. Likewise, each of the chance
nodes is subdivided into two branches to reﬂect the imperfect test
characteristics of the FAP and FPR, i.e. their Se and their Sp are not
equal to 1. The branch displaying the cows with SARA consists of the
proportion of true positives (TP), i.e. the proportion of cows which is
correctly detected as positive by the biomarker and has SARA, and of
the proportion of false negatives (FN), i.e. the proportion of cows which
is detected as “healthy” by the biomarker but is actually suﬀering from
SARA.
Similarly, the chance fork which stems from the healthy cows
consists of the proportion of true negatives (TN), i.e. the proportion of
cows detected as negative by the milk biomarker and are healthy, and
the proportion of false positives (FP), i.e. the proportion of cows de-
tected as positive by the biomarker but are healthy.
We used the framework of Cornou and Kristensen (2013) to esti-
mate the VoI of FAP and FPR. This framework accounts for how the
information is translated into action by the farmer. In the present study,
farmers were assumed to respond to the new information provided by
the biomarkers using a representative heuristic. This applies more
weight to the new information than to the previous information avail-
able (e.g., the farmer's suspicion of the existence of SARA based on prior
knowledge). When faced with the monitoring results, a dairy manager
who uses a representative heuristic will treat the cows accordingly, thus
neglecting previous information. In other words, each cow that tests
positive according to the biomarker is treated, and cows that test
negative will remain untreated. Therefore, cows with positive results
(TP and FP) will lead to TC. Cows with FN results are not treated,
leading to a case of SARA, which incurs DC. Cows with TN test results
are healthy and are therefore not treated for SARA, thus incurring no
costs. The EMV of treating only animals that receive a positive result
according to FPR or FAP is described in the following formula (Eq. (7)).
= × × × −
+ − × − + −
× × + − × −
EMV N [True Prev (Se (NCFI TC)
(1 Se) (NCFI DC)) (1 True Prev)
((Sp NCFI) (1 Sp) (NCFI TC))]
biomarkers
(7)
The VoI of the FAP versus no monitoring and the VoI of the FPR
versus no monitoring were estimated with Eqs. (8) and (9), respec-
tively.
= −VoI EMV EMVFAP versus no monitoring FAP no monitoring (8)
= −VoI EMV EMVFPR versus no monitoring FPR no monitoring (9)
2.7. Default scenario, elasticity, and sensitivity analysis
To account for the uncertainty of our input parameters and to in-
vestigate under which conditions the FAP-based models are of value,
we simulated diﬀerent scenarios. The diﬀerent scenarios simulated are
described in Table 3.
The stochastic simulations were performed in @Risk 7.5 (Palisade
Corporation, Ithaca, NY, USA). Latin Hypercube sampling was used
with a ﬁxed seeder of 1 to ensure all simulations provided repeatable
results. For all the scenarios 10,000 iterations were ran.
For all the scenarios, cumulative distribution functions (CDF) were
plotted for the EMV2 of the three decisions: (i) no monitoring, (ii)
monitoring with FPR, (iii) monitoring with FAP. Furthermore, the EMV
of the three modeled decisions were evaluated applying a stochastic
eﬃciency method called ﬁrst-degree stochastic dominance (Hardaker
et al., 1997). This technique is used to assess which decision is preferred
and it is based on the assumption that the decision maker will prefer
‘more’ rather than ‘less’. First-degree stochastic dominance is based on
relationships between the CDF of alternative decisions. Let's imagine
two decisions: (i) decision A and (ii) decision B. They are described by
CDF EMVA and CDF EMVB, respectively. The decision A dominates
decision B by ﬁrst-degree if graphically the CDF of the EMVA lies always
below and to the right of the CDF of the EMVB (Hardaker et al., 1997).
Fig. 3. Decision tree which depicts the three alternatives: i) no
monitoring subacute ruminal acidosis (SARA), ii) monitoring
SARA using the fatty acid proﬁle (FAP), iii) monitoring SARA
using the fat-to-protein ratio (FPR). a Subacute ruminal acidosis; b
Fatty acid proﬁle; c Fat-to-protein ratio; d Herd size; e True pre-
valence; f True positives; g False negatives; h True negatives; i
False positives; j Sensitivity FAP; k Speciﬁcity FAP; l Sensitivity
FPR; m Speciﬁcity FPR; n Expected monetary value of treating all
in €/farm/year; o Net cash farm income in €/cow/year; p
Treatment costs in €/cow/year; q Expected monetary value
treating none in €/farm/year; r Disease costs in €/cow/year; s
Expected monetary value of no monitoring SARA in €/farm/year;
t Expected monetary value of using a FAP-based monitoring in
€/farm/year; u Expected monetary value of using a FPR-based
monitoring in €/farm/year.
1 The NCFI consists of the total receipts minus the total expenses. Total receipts consists
of the ﬁnancial gains received by the diﬀerent activities performed by the specialized
dairy farm such as crop (e.g. wheat, barley, etc.) and dairy (milk, cull cows, calves, etc.)
as well as government payments.
2 A CDF of EMV at value x is the probability that the EMV takes a value less than or
equal to x. The values of the EMV are displayed on the horizontal axis. Because the
vertical axis represents a probability, its values lie between 0 and 1. The vertical axis
increases from 0 to 1 as the EMV values increase on the horizontal axis.
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Table 3
Description of the diﬀerent scenarios modeled to account for the uncertainty of the input data.
Name of the analysis Varying variables Fixed variables
Default scenario DCa (€/case/year) ~ Pert distribution (100, 210, 400) Se FAPd = 0.6421
Sp FAPe = 0.8877
Nf = 95g
NCFIh = €1,277/cow/yearg
Se FPRi = 0.72
Sp FPRj = 0.3143TCb (€/case/year) ~ Uniform distribution (20, 250)
True Prevc ~ ﬁtted as an exponential distribution with mean 0.1595
Elasticity analysis −1 True Prevc ~ Uniform distribution (0,1) DCa (€/case/year) = 223.33
TCb(€/case/year) = 135
Se FAPd = 0.6421
Sp FAPe = 0.8877
Nf = 95g
NCFIh = €1,277/cow/yearg
Elasticity analysis−2 DCa (€/case/year) ~ Uniform distribution (100, 400) TCb (€/case/year) = 135
True Prevc = 0.1595
Se FAPd = 0.6421
Sp FAPe = 0.8877
Nf = 95g
NCFIh = €1,277/cow/yeara
Elasticity analysis−3 TCb (€/case/year) ~ Uniform distribution (20, 250) DCa (€/case/year) = 223.33
True Prevc = 0.1595
Se FAPd = 0.6421
Sp FAPe = 0.8877
Nf = 95g
NCFIh = €1,277/cow/yearg
Sensitivity analysis−1 Se FAPd increased from 0.6421 to 0.66 and onwards by 0.02 intervals until 1 Sp FAPe = 0.8877
Nf = 95g
NCFIh = €1,277/cow/yeargDCa (€/case/year) ~ Pert distribution (100, 210, 400)
TCb (€/case/year) ~ Uniform distribution (20, 250)
True Prevc ~ ﬁtted as an exponential distribution with mean 0.1595
Sensitivity analysis−2 Sp FAPe increased from 0.8877 to 0.90 and increased onwards by 0.02 intervals
until 1
Se FAPd = 0.6421
Nf = 95g
NCFIh = €1,277/cow/yeargDCa (€/case/year) ~ Pert distribution (100, 210, 400) TCb (€/case/year) ~
Uniform distribution (20, 250)
True Prevc ~ ﬁtted as an exponential distribution with mean 0.1595
Evaluation of VoIk FAP versus no monitoring on ROCl points
of Fig. 1
10 discrete combinations of Se FAPd and Sp FAPe (Fig. 1) Nf = 95g
NCFIh = €1,277/cow/yeargDCa (€/case/year) ~ Pert distribution (100, 210, 400) TCb (€/case/year) ~
Uniform distribution (20, 250)
True Prevc ~ ﬁtted as an exponential distribution with mean 0.1595
a Disease costs.
b Treatment costs.
c True prevalence.
d Sensitivity of the fatty acid proﬁle.
e Speciﬁcity of the fatty acid proﬁle.
f Herd size.
g Hemme (2016)
h Net cash farm income.
i Sensitivity of the fat-to-protein ratio.
j Speciﬁcity of the fat-to-protein ratio.
k Value of information.
l Receiving Operating Characteristics Curve.
Fig. 4. Continuous cumulative distribution functions of the ex-
pected monetary value (EMV) in €/farm/year of (i) no monitoring
subacute ruminal acidosis (SARA) (dotted black line), (ii) mon-
itoring SARA using fatty acid proﬁle (FAP) (solid black line), (iii)
monitoring SARA using fat-to-protein ratio (FPR) (grey line) in
the default scenario1. 1 Under the default scenario the diﬀerent
input variables were parametrized as follows: the disease costs
(€/case/year) as RiskPert (100, 210, 400), the treatment costs
(€/case/year) as RiskUniform (20, 250) and true prevalence of
SARA as a ﬁtted exponential distribution with mean 0.1595. The
test characteristics of the fatty acid proﬁle and the fat-to-protein
ratio were: sensitivity (Se)= 0.64 and speciﬁcity (Sp)= 0.89 and
Se= 0.72 and Sp=0.31, respectively. The parameterized herd
size was 95. The net cash farm income was kept as €1,277/cow/
year.
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3. Results
3.1. Default scenario
Fig. 4 presents the CDF of the EMV of the three possible decisions in
the default scenario: (i) no monitoring, (ii) monitoring with FPR, (iii)
monitoring with FAP. No monitoring yielded a higher EMV than
making treatment decisions based on the FAP in 69.99% of the simu-
lations (data not shown). Furthermore, in approximately 96% of these
iterations it was better to treat none of the cows (data not shown). This
was mainly a consequence of the low True Prev (on average 0.1595,
Fig. 2) in combination with the modeled TC and DC (see Table 3 for the
input parameters modeled) that made the FAP biomarker of no value to
detect SARA.
As seen in Fig. 4, the functions of the EMV of both strategies, i.e. no
monitoring SARA (dotted black line) and monitoring SARA by means of
the FAP (solid black line) lie graphically to the right and below of the
monitoring based on the FPR (grey line). As a consequence, no mon-
itoring and monitoring with FAP had ﬁrst-degree stochastic dominance
over SARA treatment decisions based on monitoring with FPR. In other
words, the SARA treatment decisions based on FPR always led to the
lowest EMV compared to the other two decisions modeled. Treatment
decisions of SARA based on FAP always outperformed those made by
FPR, which was related to the low test performance of the latter
(Se= 0.72 and Sp= 0.31) compared to the FAP–based models
(Se= 0.64 and Sp=0.89). This phenomenon occurred for all the si-
mulated elasticity and sensitivity analyses presented below (data not
shown). Furthermore, because the EMVFPR was always the lowest of the
three decisions, the VoI of FPR is not discussed here.
3.2. Elasticity and sensitivity analyses
The results of the elasticity analysis-1 are portrayed in Fig. 5. At
average TC of €135/case/year and most likely DC of €223.33/case/
year, using FAP to detect SARA had a positive value for a True Prev
between 0.21 and 0.79 (maximum of 0.61). Outside this range, the VoI
of FAP was negative (Fig. 5).
The elasticity analysis-2 shows the eﬀect of DC in the VoI of FAP
versus no monitoring (Fig. 6a). At average TC of €135/case/year and
most likely True Prev (0.1595), the VoI of FAP increased with DC and
became positive at a DC of €259.44/case/year (Fig. 6a).
Elasticity analysis-3 shows the inﬂuence of the TC, given the most
likely DC (€223.33/case/year) and most likely True Prev (0.1595), on
the VoI of FAP (Fig. 6b). This ﬁgure displays an apparently counter-
intuitive shape because the VoI of FAP increases when the TC increase
between €20 and €35.62/case/year. In this range of TC, the EMVFAP
was higher than the EMVno monitoring corresponding to the decision to
treat all cows. As described in Eqs. (5) and (7), both the EMVall and
EMVFAP decreased as the TC increased. Nevertheless, given that the
EMVall is directly aﬀected by the TC, when the TC increased, the EMVall
decreased faster (€95 per additional €1 of TC) than the EMVFAP (€18.70
per additional €1 of TC). In the latter scenario, the TC are inﬂuenced by
the SeFAP, SpFAP and True Prev, reducing the eﬀect of the increase of the
TC (Eq. (7)). In the ﬁrst part of Fig. 6b, the VoI of the FAP is estimated
as the EMVFAP minus the EMVall and the latter is smaller than the
former. This explains why the VoI of FAP increased when the TC in-
creased. In the second part, from TC of €35.62/case/year onwards, the
VoI of FAP versus no monitoring decreased and reached negative values
when the TC were €116.22/case/year. In this part the highest EMV of
the decision ‘no monitoring’ was found when none of the cows were
treated, which is independent of the TC (Eq. (6)) and constant at
€117,931/farm/year. This value is reached by the EMVFAP when the TC
are above €116.22/case/year. From this value onwards the decision
with the highest EMV is to treat none of the cows instead of using the
FAP to make SARA treatment decisions.
Fig. 7a shows the results of the sensitivity analysis-1. Under the
input parameters deﬁning the default scenario (Table 3), the VoI of FAP
versus no monitoring always remained negative even when Se of FAP
could be improved up to 1.00 with the same Sp (0.89). Contrastingly, if
the Sp would increase up to 0.95 with the same Se (0.64), the VoI of
FAP would become positive. If the Sp could be improved up to 1 while
maintaining the same Se, the VoI of FAP versus no monitoring will be
on average €543/farm/year (Fig. 7b).
The results of investigating the VoI of FAP at 10 diﬀerent points of
the ROC curve of Fig. 1 demonstrated that under all the possible current
combinations of Se and Sp, the VoI remained negative (Fig. 7c).
Moreover, under the default scenario, a higher the Se associated with a
Fig. 5. Results of the elasticity analysis-11 which show the eﬀect of true prevalence of
subacute ruminal acidosis (SARA) on the value of information (VoI) of the fatty acid
proﬁle (FAP) to detect SARA versus no monitoring. 1In the elasticity analysis-1 the disease
costs and treatment costs were kept at their most probable deterministic values that were
€223.33/case/year and €135/case/year, respectively. The sensitivity and speciﬁcity of
the fatty acid proﬁle were kept as 0.64 and 0.89, respectively. The herd size was kept as
95 and the net cash farm income as €1,277/cow/year.
Fig. 6. Results of the elasticity analyses-21 and − 32 which present the eﬀect of the
disease costs (DC) (a) and treatment costs (TC) (b) on the value of information (VoI) of
fatty acid proﬁle (FAP) to detect subacute ruminal acidosis versus no monitoring. 1In
elasticity analysis-2, the eﬀect of the DC on the VoI of the FAP was estimated by ac-
counting the DC as a uniform distribution (Riskuniform (100,400)) while keeping the TC
at €135/case/year, the true prevalence at 0.16, the sensitivity of the FAP and the spe-
ciﬁcity of the FAP at 0.64 and 0.89, respectively, the herd size at 95 and the net cash farm
income at €1,277/cow/year. 2 In the elasticity analysis-3 the eﬀect of the TC on the VoI of
the FAP was estimated by accounting the TC as a uniform distribution (Riskuniform
(20,250)) and the DC at €233.33/case/year, and the rest of the variables remained as in
the elasticity analysis-2.
C. Rojo-Gimeno et al. Livestock Science 211 (2018) 30–41
36
lower the Sp of FAP always resulted in a reduction of the VoI.
4. Discussion
The VoI provided by FAP was negative in the default scenario
(Fig. 4). In other words, using the modeled input parameters of this
scenario, which involved large intervals, the EMV of no monitoring
SARA and making herd-level decisions was higher than the EMV of
using the FAP to detect SARA to treat individual cows. To our knowl-
edge this is the ﬁrst study that attempts to estimate the VoI of milk
biomarkers to monitor SARA. Therefore, we were unable to compare
our results with existing literature. Nevertheless, our outcome coincides
with the rather low VoI obtained for diﬀerent Precision Agriculture
(Bennett and Pannell, 1998; O’Connell et al., 1999; Pannell and Glenn,
2000) and Precision Livestock MS (Jørgensen, 1993; van Asseldonk
et al., 1999; Bewley et al., 2010; Jago et al., 2011; Giordano, 2014; Cha
et al., 2016; Down et al., 2017). In these studies, informed decisions
based on additional information do not always result in better decisions
made as compared to no monitoring. Cha et al. (2016) revealed that the
value of pathogen speciﬁc information in treating clinical mastitis in
dairy cows was rather low. In contrast, the highest VoI was derived
when the farmer assumed that the pathogen causing the clinical mas-
titis was the one with the highest incidence in the herd and no pa-
thogen-speciﬁc information was obtained. The proﬁtability of an estrus
detector for dairy cows was investigated by van Asseldonk et al. (1999).
In the best case scenario, when the detection rate was improved from
50% to 90% at ﬁrst insemination, and assuming a conception rate of
40% and the yearly fat protein corrected milk production was 7,580 kg/
cow/year, the beneﬁt entailed through the detector was only €0.58 per
100 kg fat protein corrected milk per year (van Asseldonk et al., 1999).
Moreover, the detection rate did not show a linear relationship with
gross margin, which was highly dependent on the conception rate and
the milk production. In fact, the higher the reference conception rate
and milk production, the lower the additional beneﬁts resulting from an
improved estrus detection (van Asseldonk et al., 1999). Their results
were conﬁrmed by several recent studies demonstrating that, on
average, the use of automatic estrus detection sensors yielded rather
low beneﬁts which were highly dependent on the performance of the
reference method in place (Jago et al., 2011; Giordano, 2014). In ad-
dition, Giordano (2014) revealed that the beneﬁts attained were
sometimes lower than the costs of implementing the MS. Furthermore,
Jørgensen (1993) found that the beneﬁts accrued could barely cover the
costs of individual identiﬁcation tags when precise pig weighing was
used as compared to batch delivery of pigs.
The beneﬁts of MS are scenario speciﬁc (Bewley et al., 2010; Jago
et al., 2011; Giordano, 2014). These studies have explored several
scenarios to better understand the circumstances in which the in-
vestigated MS were beneﬁcial for the farmer. Similarly, in our study
sensitivity and elasticity analyses were conducted to gain insights into
the conditions under which the monitoring with FAP would enhance
SARA treatment decision making. The FAP showed a positive VoI (i) for
(sub-)herds in which the True Prev of SARA is medium to high (Fig. 5),
and (ii) when treating SARA can lead to more than marginal im-
provements in economic performance per cow, i.e. when TC are lower
than €116/case/year (Fig. 6(a)) or when DC are higher than €260/
case/year (Fig. 6(b)), and when the Sp of the test would be improved up
to 0.95 while maintaining the same Se (Fig. 7(b)). When one or more of
these conditions are not met, the window in which the FAP is of eco-
nomic value narrows. Under medium prevalence levels of SARA, the use
of FAP to detect SARA does not improve farm's economic performance.
Therefore, implementation of the FAP milk biomarkers could be prof-
itable in a herd with a higher prevalence than an average herd, as the
economic value rose when prevalence increased to medium levels. Our
results suggest that making SARA treatment decisions by means of FAP
monitoring would be proﬁtable for the 32 out of the 87 herds from
previous studies used to ﬁt the True Prev distribution with a prevalence
of SARA between 0.21 and 0.58 (Supplementary material-1) (Fig. 5).
Alternatively, it could be proﬁtable to use the FAP milk biomarker in
subgroups of a herd that are at a higher risk of developing SARA such as
cows which are between 15 and 30 days in milk with individual
Fig. 7. Results of the sensitivity analysis-11 (a), sensitivity analysis-22 (b) and of the discrete analysis of the 10 diﬀerent combinations of sensitivity (Se) and speciﬁcity (Sp) of fatty acid
proﬁle (FAP) to monitor subacute ruminal acidosis3 (c). 1In the sensitivity analysis-1 all variables were kept as in the default scenario and the sensitivity of the FAP was increased by
intervals of 0.02 until sensitivity reached 1. 2 In the sensitivity analysis-2 all variables were kept as in the default scenario and the speciﬁcity of the FAP was increased by intervals of 0.02
until speciﬁcity reached 1. 3 The 10 combinations of sensitivity and speciﬁcity of the fatty acid proﬁle (FAP) used to estimate the value of information of FAP versus no monitoring are
displayed in the receiving operating characteristics (ROC) curve of the FAP-based models in Fig. 1, all the other variables remained as in the default scenario.
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compound feeding, which is rapidly built up during this period. As we
did not account for the additional costs of obtaining the information,
these positive values represent the maximum amount that the farmer
could reasonably pay, from an economic perspective, for the additional
information without incurring losses. This only holds true, however,
when the use of the FAP biomarker entails no ﬁxed investment or im-
plementation costs, and hence only implies a variable cost when it is
used. Our results are upper limit estimates as we assumed that the
treatment (combination of buﬀer and adaptation of the diet) will yield
an immediate 100% cure rate, which is not always the case (Colman
et al., 2010, 2012). In the future, this conclusion could potentially be
nuanced if new research can decrease the uncertainty associated with
the treatment and disease costs. The potential value may also depend on
market conditions. For instance when milk prices are high and feed
prices are low, it is likely that the diﬀerence between DC and TC be-
comes larger, so that the economic VoI of biomarkers to detect SARA
would increase.
In all the simulated scenarios, the use of the FPR biomarkers to
decide on SARA treatment led to a decrease in farm proﬁtability (Fig. 4
for default scenario; data for the other scenarios are not shown but are
available upon request). The performance of FPR-based models to di-
agnose SARA is quite poor (Guegan et al., 2015), resulting in ﬁrst-de-
gree stochastic dominance by both of the alternative decisions: (i) no
monitoring and (ii) FAP-based monitoring (Fig. 4). This might explain
why farmers who have an automatic milking system with an in-
corporated MS to measure FPR do not use it often or do not request it
regularly from the provider (Steeneveld and Hogeveen, 2015). More-
over, French organic dairy farmers showed a very low acceptance of the
diﬀerence between the milk fat and milk protein content levels (i.e. a
proxy for the FPR used in Belgium) as an indicator of prevalence of
SARA and Swedish farmers have rejected this indicator altogether
(Duval et al., 2016). Given that the FAP-based models have shown a
better performance than the FPR, it suggests that the FAP will be a
better monitoring tool, when it becomes commercially available, to
detect SARA than the FPR.
From an animal health and welfare point of view, both veterinarians
and MS researchers wish to avoid false negatives, thus a high Se is
desired. However, in our study, under the default scenario, we showed
that even when the Se of the FAP was improved up to 1.00, the decision
of no monitoring SARA in the herd remained the decision with the
highest EMV (Fig. 7a). Given the low prevalence of SARA (Fig. 2), we
demonstrated further that from an economic perspective, attempts to
improve Sp are the most interesting. If Sp was increased up to 1.00, the
use of FAP to monitor SARA would become proﬁtable (Fig. 7b). Ac-
cordingly, the FAP needed to have a Sp higher than 0.95 maintaining
the same Se of 0.64 to achieve a positive VoI. These results are in line
with the desires of farmers, as they prefer to have as few false alarms as
possible and therefore a MS with a high Sp (Claycomb et al., 2009;
Kamphuis et al., 2010; Mollenhorst et al., 2012). Given the plausible
combinations of Se and Sp of FAP, the VoI of the current FAP-based
models always remains negative (Fig. 7c). Improvement of both the Se
and Sp of an MS would require a large amount of time, money, and
resources. We therefore advocate that an ex-ante evaluation of im-
provement of the test characteristics is performed ﬁrst, as done in the
current study in order to guide MS developers to optimize the allocation
of ﬁnite resources.
The data scarcity of the input parameters (TC, DC, True Prev) to
evaluate the EMV of the three potential decisions to monitor and treat
SARA is a limitation of this study. In particular, the data on TC and DC
were very scant. The economic impact of dairy metabolic diseases has
been neglected in the literature (Raboisson et al., 2015; Van der Voort
et al., 2017), but obtaining accurate estimates of these values was be-
yond the scope of this study. We used the methodology proposed by
Hardaker and Lien (2010) who advocate for the integration of fre-
quentist and subjective distributions for variables for which data scar-
city is a problem. They advise the use of distributions which are
developed based on a combination of very scarce data with expert
judgments. The authors argued that studies also should pay attention to
issues arising when little data are available, as in the present study,
because an exclusive focus on problems or questions for which either no
uncertainty occurs (deterministic values would be used) or uncertainty
but a large dataset is available (frequentist distributions would be
used), could divert attention from more important questions, and could
lead to suboptimal use of resources and investments (Hardaker and
Lien, 2010). The goal of the present study was to provide re-
commendations to MS developers regarding which variables aﬀect the
value of their designed MS. As these results play a crucial role in
guiding researchers of MS towards an optimal allocation of material,
economic and human resources when optimizing their tools, the results
from the sensitivity and elasticity analyses were more enriching than
providing a very accurate estimate of the VoI of FAP to detect SARA.
Similar to previous studies assessing the economic impact of MS
(Bewley et al., 2010; Jago et al., 2011; Giordano, 2014; Down et al.,
2017; Van De Gucht et al., 2018) that used simulations to investigate
diﬀerent situations, we examined several scenarios simulating sensi-
tivity and elasticity analysis not only to compensate for the scarcity of
data, but also to oﬀer insights on which are the most inﬂuential factors
and which combination of factors yield a positive VoI of FAP.
Our model assumed that farmers will know a priori the EMVall and
EMVnone and will choose the option entailing the highest EMV (Eq. (4)).
However, this assumption may be optimistic, as farmers may lack in-
formation on the variables aﬀecting the EMVno monitoring, such as the
true prevalence of SARA, the TC and the DC. Therefore, the results of
the decision model presented in this study favors the decision of no
monitoring over monitoring of SARA with milk biomarkers. Moreover,
the results, the model, and its implications should not be extrapolated
to other situations and health problems. First, the situation may be
diﬀerent if the MS is able to detect several health problems at once. For
instance, milk FAP is also capable to predict the appearance of negative
energy balance and ketosis in dairy cows (Jorjong et al., 2014, 2015).
FPR is also used to assess the protein and fat percentage, important
proxies for milk quality. Presumably, if the information provided by
these tests also leads to improved decision making regarding other
problems, their intrinsic VoI would be higher (Verstegen et al., 1995).
Second, the situation would also be diﬀerent if the MS changes the
choice set (e.g. such as when the MS allows to change the kind of de-
cisions that can be made). In our study, monitoring using milk bio-
markers makes it possible to make decisions at the individual cow level.
In contrast, when no monitoring system was used only decisions at the
herd level could be made. Sometimes no herd level decision is possible,
such as when using MS to detect estrus (e.g. progesterone sensor, ac-
tivity meters, etc.) (van Asseldonk et al., 1999; Jago et al., 2011; Rutten
et al., 2014; Giordano, 2014). The objective of this study was to in-
vestigate the economic VoI of milk biomarkers to detect SARA. Con-
sequently, only the economic perspective was explored. However, the
use of MS is considered as a means to enhance animal welfare. SARA is
known to seriously impair cows’ welfare as it is linked with involuntary
early culling (Enemark, 2009), including the eﬀect on animal welfare
into the economic analysis may have provided higher VoI of FAP.
Furthermore, it was assumed that a representative heuristic was
used by the dairy farmer when he/she faced the monitoring results used
to make SARA treatment decisions. In other words, the farmer dis-
regards the previous information about the disease and uses only the
new monitoring results to treat SARA. This is a behavioral assumption
that can in theory be challenged. A decision maker may react to new
information in three ways: using a bayesian heuristic, a representa-
tiveness heuristic and conservativism heuristic (Tversky and
Kahneman, 1982). Whether the information is embedded into a deci-
sion support system or not may have an inﬂuence on the heuristic used
to make treatment decisions. For instance, if the monitoring informa-
tion is accompanied by advice, the farmer may be more prone to use a
representative heuristic. Previous studies reported that people rely
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more on simpler heuristics than the bayesian heuristic such as the re-
presentativeness and conservativism heuristics (Gans et al., 2007;
Barham et al., 2014). A representativeness heuristic was hypothesized
by Rutten et al. (2014) to be used by dairy farmers who might want to
trust the MS blindly. In contrast, a conservativism heuristic was thought
to be used by dairy farmers using estrus detection sensors because alerts
generated did not result in earlier insemination nor better reproductive
performance (Steeneveld et al., 2015). In the present study a sensitivity
analysis of how using the three possible heuristics may aﬀect the VoI of
the MS was not performed. Further research should investigate the
heuristics used by farmers when faced with the results of the MS.
5. Conclusion
The current study presents a simple stochastic decision tree model
that can be used to examine the conditions under which the VoI of a MS
is beneﬁcial. Under all the simulated scenarios, decisions based on the
FPR always lead to the lowest EMV. The results of our ex-ante analysis
using several scenarios suggested that, on average, the VoI of FAP to
detect SARA was low and did not outperform the decisions that were
made without monitoring of SARA. On the contrary, when the True
Prev was between 0.21 and 0.79, when the TC costs were lower than
€116/case/year and DC were higher than €260/case/year, the FAP
showed a positive VoI, rendering FAP an appropriate monitoring tool to
identify SARA under those conditions. In addition, increasing the Sp of
the test will yield a higher value than improving the Se. The results of
this study can guide the developers of the FAP-based models to best
allocate limited resources in their quest to design a MS to diagnose
SARA. To avoid the suboptimal use of resources, we advocate that de-
velopers of MS perform an ex-ante evaluation of the potential beneﬁts
of their tools, similar to the one presented in this study, during the
research phase and before they are commercialized.
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Appendix A
In total four datasets were used to estimate the test characteristics of FPR (dataset 1.1, dataset 1.2, dataset 2, dataset 4) and of FAP (dataset 1.1
Table A1
Overview of the four datasets from acidosis induction experiments in dairy cows that were used to estimate the test characteristics of the fatty acid proﬁle and fat-to-protein ratio (adapted
from Colman et al., 2015).
Dataset Number of
cows
DIMa (µb
+ SDc)
Period
(days)
Ration Sampling time Number of
samples
1.1d 3 127±61.9 33 (1) Control diet (F/Ce ratio of 65/35)
(2) Standard concentrate was replaced stepwise by wheat-based
concentrate
(3) Total amount of concentrate increased
(4) Buﬀer addition
(5) Control diet
Rumen pH, milk FAPf and FPRg (1st
day diet 1; 4th day diet 2; 4th day diet
3; 2nd day diet 4; 4th–7th day diet 5)
49h
1.2d 3 170±30.3 3 × 21 (1) Day 1 to day 13: Control diet (F/Ce ratio of 68/32)
(2) Day 14 to day 21: standard concentrate was substituted
stepwise by concentrate rich in quickly fermentable
carbohydrates until the total percentage of concentrate B
reached 100%
Rumen pH, milk FAPf and FPRg (day
13th - day 21st of each of the 3
periods)
80i
2j 12 236±42 42 (1) Week 1: control ration
(2) Week 2–5: standard concentrate was gradually changed by
wheat-based concentrate
(3) Week 6: total concentrate is increased
Rumen pH, milk FAPf and FPRg (2nd
day and 7th day of each week)
144k
4 3 146±189 3 × 21 (1) Day 1 to day 13 starch-rich, sugar-rich or starch-and protein
rich concentrate, F/Cd ratio of 75/25
(2) Day 14 to day 18: The amount of concentrate was increased
stepwise by 5% till the F/Cr ratio reached 50/50
(3) Day 19 to day 21: the cows were fed a diet with a F/Cd ratio
of 50/50
Rumen pH, milk FAPf and FPRg (10th
day and 21st day of each period)
107
a Days in milk.
b Average value.
c Standard deviation.
d Colman et al. (2012).
e Forage/concentrate ratio.
f Fatty acid proﬁle.
g Fat-to-protein ratio.
h For one sample the ruminal pH could not be reliably measured so only 48 samples were used to estimate the sensitivity and the speciﬁcity of FAP and FPR.
i For two samples the ruminal pH could not be reliably measured so only 78 samples were used to estimate the sensitivity and the speciﬁcity of FAP and FPR.
j Colman et al. (2010).
k For 12 samples the ruminal pH could not be reliably measured so only 132 samples were used to estimate the sensitivity and the speciﬁcity of FAP.
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and 1.2). An overview and brief description of each dataset is given below and in Table A1
Dataset 1. Colman et al. (2012) describes the experimental design, sampling and rations contained in dataset 1 which consisted of two sub-
experiments (referred as to experiment 1.1 and experiment 1.2) conducted in the Netherlands (Schothorst Feed Research, Lelystad, the Netherlands).
The induction of acidosis was achieved by a stepwise replacement of a standard concentrate (concentrate A) by a concentrate rich in quickly
fermentable carbohydrates up to 100% (concentrate B), followed by an increase of the total amount of concentrate B. In experiment 1.1 three rumen-
ﬁstulated cows were administered ﬁve diets subsequently during 33 days. Diet 1 (control) consisted of a diet based on a forage/concentrate ratio (F/
C) of 65/35. In diet 2, concentrate B replaced stepwise concentrate A until concentrate B reached 100% of the concentrate administered. In Diet 3 the
total amount of concentrate B was increased depending on the cow by reaching the following F/C ratios: 48/52, 42/58, 24/76. Diet 4 consisted of a
treatment with a buﬀer solution. Diet 5 was a control ration. A 3× 3 Latin square design was applied in experiment 1.2 which consisted of three
periods elapsing for 21 days. A control diet (F/C ratio of 68/32) was provided to three cows during the ﬁrst 14 days of the period. In the last seven
days concentrate B replaced stepwise concentrate A (from 100% concentrate A to 44% concentrate A and 56% concentrate B) and the amount of
concentrate was increased until a F/C of 46/54. Three buﬀering solutions were added during the entire period.
Dataset 2. The experimental design, sampling and rations contained in this dataset are detailed elsewhere (Colman et al., 2010). The experiment
lasted six weeks in total and was conducted in the Netherlands (Provimi Research and Innovation Centre, Velddriel, the Netherlands). The ﬁrst week
was the control week and consisted of 12 rumen-ﬁstulated cows that were fed a mixture of grass silage and maize silage supplemented with standard
concentrate according to lactation stage and milk yield. From the second to the ﬁfth week, a wheat-based concentrate gradually replaced the
standard concentrate. From the beginning, the ration was supplemented with feed additives (yeast, vitamin E and buﬀer) in order to prevent SARA.
In the last week, depending on the cow's milk yield, the total amount of wheat-based concentrate was incremented by 2–4 kg/day.
Dataset 4. This dataset consists of unpublished data of an experiment performed in the Netherlands (Schothorst Feed Research, Lelystad, the
Netherlands). In this experiment a 3× 3 Latin square design was applied in which three dietary treatments were tested in three cows for three
periods of 21 days. The three dietary treatments consisted of three concentrates, with either an average amount of fermentable crude protein and a
high amount of fermentable starch (treatment 1) or sugar (treatment 2) or with a high amount of fermentable starch and a high amount of
fermentable crude protein (treatment 3). During the ﬁrst 13 days of the period, the cows received a diet with a F/C ratio of 75/25. From day 14 to 18
the amount of concentrate was increased in steps of 5% until the F/C ratio reached 50/50. This diet was also provided during the last three days of
the 21-day period. Forage consisted of a mixture of corn silage, grass silage, and soybean meal (45/45/10).
Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.livsci.2018.02.001.
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